Litcius/Paper detail

No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification

Stéphane Paul, Nicolas Williet, Stéphane Nancey, Pauline Veyrard, Gilles Boschetti, Jean–Marc Phelip, Bernard Flourié, Xavier Roblin

2020Digestive Diseases and Sciences11 citationsDOI

Topics & Concepts

RegimenMedicineAdalimumabInternal medicinePharmacokineticsGastroenterologySurgeryDiseaseInflammatory Bowel DiseaseBiosimilars and Bioanalytical MethodsMicroscopic Colitis